Mutations in Fibrillin-1 Cause Congenital Scleroderma: Stiff Skin Syndrome

Latent Transforming Growth Factor β-binding Proteins and Fibulins Compete for Fibrillin-1 and Exhibit Exquisite Specificities in Binding Sites

(2009) Robert N. Ono et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Transforming growth factor β as a therapeutic target in systemic sclerosis

(2009) John Varga et al.   Nature Reviews Rheumatology

Scleroderma

(2009) Armando Gabrielli et al.   NEW ENGLAND JOURNAL OF MEDICINE

Tissue stiffness, latent TGF-β1 Activation, and mechanical signal transduction: Implications for the pathogenesis and treatment of fibrosis

(2009) Boris Hinz   Current Rheumatology Reports

The Stiff Skin Syndrome

(2008) Theodore Liu et al.   ARCHIVES OF DERMATOLOGY

Fibrillin–integrin interactions in health and disease

(2008) Jelena Jovanović et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

Vascular Disease in Scleroderma

(2008) Fredrick M. Wigley   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Integrins and the activation of latent transforming growth factor β1 – An intimate relationship

(2008) P WIPFF et al.   EUROPEAN JOURNAL OF CELL BIOLOGY

PERSPECTIVE ARTICLE: Growth factors and cytokines in wound healing

(2008) Stephan Barrientos et al.   WOUND REPAIR AND REGENERATION

Cellular and molecular mechanisms of fibrosis

(2007) TA Wynn   JOURNAL OF PATHOLOGY